DR

David Rodman

Chief Development Officer

Mineralys Therapeutics

Roles

Chief Development OfficeratMineralys Therapeutics
Chief Medical OfficeratSionna Therapeutics

Mineralys Therapeutics Pipeline

DrugIndicationPhase
Lorundrostat (MLS-101)Uncontrolled HypertensionPhase 2
Next-generation aldosterone synthase inhibitorsHypertensionPreclinical